Author(s): Pierre Fenaux, Marco Gobbi, Patricia L. Kropf, et. al. EHA Library. Fenaux P. Jun 15, 2019; 267462; S879 Abstract: S879 Session topic: 4. Acute myeloid leukemia – Clinical Background G is a next generation hypomethylating agent (HMA) given subcutaneously (SC) which provides prolonged in vivo exposure to its active metabolite decitabine,...
Pro zobrazení tohoto obsahu je třeba být přihlášen.